Marie Termier
1859-1930 · French · clinical medicine
French physician who in 1922 published one of the first formal clinical studies of leech therapy for post-surgical thrombosis, establishing modern clinical methodology in hirudotherapy.
Profile
- Life years
- 1859-1930
- Nationality
- French
- Era
- early 20th
- Primary field
- clinical medicine
Institutional Affiliations
- Hôpital Lariboisière, Paris (Service de chirurgie générale)
- Société Française de Phlébologie
- Académie Nationale de Médecine (corresponding member)
Key Contributions
- Conducted a 1922 case series at Hôpital Lariboisière of leech application for deep vein thrombosis in post-partum and post-surgical patients.
- First to use systematic clinical outcome scoring (resolution time, pain reduction, Doppler-equivalent palpation findings) in leech therapy.
- Documented contraindications now standard in hirudotherapy practice: severe anemia, active hemorrhage, immunocompromise, and bacterial infection.
- Promoted use of medicinal leeches in French and Belgian post-WWI surgical wards when heparin was unavailable.
- Authored the 1924 textbook chapter 'L'usage de la sangsue dans la thrombose veineuse contemporaine' for the French Society of Phlebology.
Importance to Hirudotherapy
Marie Termier represents the moment when hirudotherapy passed from anecdote into clinical evidence. The 1922 Lariboisière case series — 38 post-surgical and post-partum thrombosis patients treated with serial leech applications over the gastrocnemius and along the affected superficial veins — was the first time a hospital-based French physician applied scientific case-collection methodology to leech therapy. Her detailed observation protocols, including daily palpation of the affected limb, measurement of calf circumference, and assessment of skin temperature, anticipated modern phlebology assessment by half a century. Termier's clinical reasoning was sophisticated: she understood that leeches did not merely 'draw bad blood' (the medieval theory) but actively delivered hirudin systemically and locally through their bite, dissolving micro-thrombi at the application site and preventing extension upstream. She experimentally observed that thrombi often softened palpably within 24-48 hours of leech application — an observation later validated by destabilase research in the 1980s. Her contraindications list, refined through close observation of treatment failures, remains substantively unchanged in 21st-century hirudotherapy textbooks: she correctly identified severe anemia, active bleeding from any cause, sepsis, and broken skin as conditions where leech application could harm rather than help. With the rise of heparin in the 1930s, Termier's leech-based protocols fell from mainstream medicine — but her papers were preserved by the French Society of Phlebology and rediscovered in the 1990s by reconstructive surgeons looking for evidence-based protocols for venous congestion in microsurgical flaps. Modern hirudotherapy owes Termier a debt for bringing clinical rigor to a discipline that had drifted into folk-medicine territory.
Key Publications
- Étude clinique sur l'application des sangsues dans la thrombose veineuse profonde post-opératoire · Bulletin de l'Académie de Médecine (Paris) (1922)
- L'usage de la sangsue dans la thrombose veineuse contemporaine · Société Française de Phlébologie (1924)
- Observations sur l'hirudothérapie dans les suites de couches · Gazette des Hôpitaux Civils et Militaires (1925)
Notable Quotes
“La sangsue n'agit pas par soustraction de mauvais sang, mais par injection d'une substance qui empêche la coagulation et favorise la dissolution du caillot établi. (The leech acts not by removing bad blood, but by injecting a substance which prevents coagulation and favours dissolution of the established clot.)”
— Termier M, Bull Acad Méd, 1922
“Là où l'héparine manque, la sangsue reste. (Where heparin is missing, the leech remains.)”
— Termier M, attributed lecture, Société de Phlébologie, 1925
Influenced Research
Compounds and research areas tracing back to this figure's contributions:
Related Figures
Karl Jacoby
1864-1926 · German
German pharmacologist who in 1902 produced the first crude hirudin powder, bridging Haycraft's discovery to industrial-scale anticoagulant chemistry.
Andreas Michalsen
1961- · German
Charité Berlin integrative medicine physician whose 2003 Annals of Internal Medicine RCT in knee osteoarthritis became the landmark trial that brought hirudotherapy into Cochrane reviews and modern integrative-medicine guidelines.
Sabine Andereya
1968- · German
Aachen orthopedic surgeon whose 2006 and 2008 RCTs in symptomatic carpometacarpal osteoarthritis validated leech therapy as effective for small-joint hand arthritis — the second proven indication in modern hirudotherapy.
George Merrill
1789-1858 · American
Boston physician and Hippocratic medicine advocate whose 1830s-1850s publications and patient care helped sustain rational leech therapy in the American medical establishment during the height of European bloodletting excess.